These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33412823)

  • 1. [Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].
    Profili F; Ballo P; Balzi D; Bellini B; Bartalocci S; Zuppiroli A; Voller F; Francesconi P
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):308-314. PubMed ID: 33412823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities.
    Deiana G; Azara A; Dettori M; Delogu F; Vargiu G; Gessa I; Arghittu A; Tidore M; Steri G; Castiglia P
    BMC Public Health; 2021 Jan; 21(1):83. PubMed ID: 33413218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis.
    Calagnan E; Gobbato M; Burba I; Del Zotto S; Toffolutti F; Serraino D; Tonutti G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):323-329. PubMed ID: 33412825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
    Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions.
    Laires PA; Nunes C
    Acta Med Port; 2020 Nov; 33(11):720-725. PubMed ID: 32707029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
    PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interrupting the chains of transmission of COVID-19 in Italy: survey among the Prevention Departments].
    Salmaso S; Zambri F; Renzi M; Giusti A
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):33-41. PubMed ID: 33412792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excess mortality risk in nursing care homes before and during the COVID-19 outbreak in Mantua and Cremona provinces (Lombardy Region, Northern Italy)].
    Ballotari P; Guarda L; Giacomazzi E; Ceruti A; Gatti L; Ricci P
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):282-287. PubMed ID: 33412820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the excess mortality and factors associated with deaths from COVID-19 versus other causes in Central Tuscany (Italy) in 2020.
    Levi M; Cipriani F; Romeo G; Balzi D
    Epidemiol Prev; 2021; 45(6):496-503. PubMed ID: 35001596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy].
    Azzolina D; Magnani C; Gallo E; Ferrante D; Gregori D
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):252-259. PubMed ID: 33412817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Describing the epidemic trends of COVID-19 in the area covered by Agency for Health Protection of the Metropolitan Area of Milan.
    Tunesi S; Murtas R; Riussi A; Sandrini M; Andreano A; Greco MT; Gattoni ME; Guido D; Gervasi F; Consolazio D; Adreoni L; Decarli A; Bergamaschi W; Russo AG
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):95-103. PubMed ID: 33412799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-morbid conditions in COVID-19 patients in Uttarakhand state of India.
    Goel D; Kumar S
    J Glob Health; 2021 Feb; 11():03029. PubMed ID: 33692884
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 mortality among migrants living in Italy.
    Canevelli M; Palmieri L; Raparelli V; Punzo O; Donfrancesco C; Lo Noce C; Vanacore N; Brusaferro S; Onder G;
    Ann Ist Super Sanita; 2020; 56(3):373-377. PubMed ID: 32959804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID-19) patients: Analysis of the Tuscany regional database.
    Bellini B; Cresci B; Cosentino C; Profili F; Bartolacci S; Scoccimarro D; Voller F; Balzi D; Francesconi P; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):769-773. PubMed ID: 33549434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.